Reference SummaryPapa A, Cell 2014 Apr 24;157(3):595-610
Title |
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. | ||||||||||
Authors |
Papa A; Wan L; Bonora M; Salmena L; Song MS; Hobbs RM; Lunardi A; Webster K; Ng C; Newton RH; Knoblauch N; Guarnerio J; Ito K; Turka LA; Beck AH; Pinton P; Bronson RT; Wei W; Pandolfi PP | ||||||||||
Journal |
Cell | ||||||||||
Volume |
157 | ||||||||||
Issue |
3 | ||||||||||
Year |
2014 | ||||||||||
Pages |
595-610 | ||||||||||
Abstract |
PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous Pten(C124S/+) and Pten(G129E/+) cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten(+/-) counterparts, whereas this difference is no longer apparent between Pten(C124S/-) and Pten(-/-) cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN. | ||||||||||
Links |
J:214411 – MGI References 24766807 – National Library of Medicine/PubMed |
||||||||||
Strain Notes
|
|||||||||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| C57BL/6 | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
73.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
79.3 - 85 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
86.5 - 91.9 |
||
| C57BL/6 | CNS - Brain - Cerebellum hamartoma | CNS - Brain - Cerebellum |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | CNS - Brain - Cerebellum hamartoma | CNS - Brain - Cerebellum |
0 |
||
| B6.Cg-Ptentm3.1Ppp/+ | CNS - Brain - Cerebellum hamartoma | CNS - Brain - Cerebellum |
25.9 |
||
| B6.Cg-Ptentm4.1Ppp/+ | CNS - Brain - Cerebellum hamartoma | CNS - Brain - Cerebellum |
25 |
||
| C57BL/6 | Gallbladder papilloma | Gallbladder |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Gallbladder papilloma | Gallbladder |
46.7 - 50 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Gallbladder papilloma | Gallbladder |
60 - 82.8 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Gallbladder papilloma | Gallbladder |
78.4 - 89.2 |
||
| C57BL/6 | Intestine polyp | Intestine |
0 - 6.25 |
||
| B6.129S1-Ptentm1Ppp/+ | Intestine polyp | Intestine |
66.7 - 83.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Intestine polyp | Intestine |
80 - 82.8 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Intestine polyp | Intestine |
83.8 - 86.5 |
||
| C57BL/6 | Leukocyte - Lymphocyte hyperplasia | Leukocyte - Lymphocyte |
0 |
||
| C57BL/6 | Leukocyte - Lymphocyte hyperplasia | Lymph node |
0 - 6.7 |
||
| B6.129S1-Ptentm1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Leukocyte - Lymphocyte |
40 |
||
| B6.129S1-Ptentm1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Lymph node |
93.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Leukocyte - Lymphocyte |
85.7 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Lymph node |
97.5 - 100 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Leukocyte - Lymphocyte |
85.7 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Leukocyte - Lymphocyte hyperplasia | Lymph node |
97.3 - 100 |
||
| C57BL/6 | Liver adenoma | Liver |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Liver adenoma | Liver |
0 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Liver adenoma | Liver |
5.0 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Liver adenoma | Liver |
10.8 - 13.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Lung adenoma | Lung |
observed |
||
| B6.129S1-Ptentm1Ppp/+ | Mammary gland adenocarcinoma | Mammary gland |
15.6 - 24.1 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Mammary gland adenocarcinoma | Mammary gland |
22.5 - 33.3 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Mammary gland adenocarcinoma | Mammary gland |
24.3 - 37.5 |
||
| B6.129S1-Ptentm1Ppp/+ | Mammary gland hyperplasia | Mammary gland |
28.9 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Mammary gland hyperplasia | Mammary gland |
22.5 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Mammary gland hyperplasia | Mammary gland |
18.9 |
||
| C57BL/6 | Mammary gland lesion | Mammary gland |
6.25 |
||
| B6.129S1-Ptentm1Ppp/+ | Mammary gland lesion | Mammary gland |
69.0 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Mammary gland lesion | Mammary gland |
66.7 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Mammary gland lesion | Mammary gland |
66.7 |
||
| C57BL/6 | Pituitary gland adenoma | Pituitary gland |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Pituitary gland adenoma | Pituitary gland |
68 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Pituitary gland adenoma | Pituitary gland |
55.6 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Pituitary gland adenoma | Pituitary gland |
25 |
||
| C57BL/6 | Prostate gland adenocarcinoma | Prostate gland |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Prostate gland adenocarcinoma | Prostate gland |
13.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Prostate gland adenocarcinoma | Prostate gland |
24.1 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Prostate gland adenocarcinoma | Prostate gland |
13.5 |
||
| C57BL/6 | Prostate gland prostatic intraepithelial neoplasia (PIN) | Prostate gland |
6.7 |
||
| B6.129S1-Ptentm1Ppp/+ | Prostate gland prostatic intraepithelial neoplasia (PIN) | Prostate gland |
63.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Prostate gland prostatic intraepithelial neoplasia (PIN) | Prostate gland |
62.1 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Prostate gland prostatic intraepithelial neoplasia (PIN) | Prostate gland |
54.1 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Thyroid gland adenocarcinoma | Thyroid gland |
8.1 |
||
| C57BL/6 | Thyroid gland adenoma | Thyroid gland |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Thyroid gland adenoma | Thyroid gland |
9.5 - 13.3 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Thyroid gland adenoma | Thyroid gland |
6.9 - 39.3 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Thyroid gland adenoma | Thyroid gland |
27.0 - 48.6 |
||
| C57BL/6 | Thyroid gland cyst | Thyroid gland |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Thyroid gland cyst | Thyroid gland |
50 - 61.9 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Thyroid gland cyst | Thyroid gland |
39.3 - 55 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Thyroid gland cyst | Thyroid gland |
45.9 - 54.1 |
||
| C57BL/6 | Uterus adenoma | Uterus |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Uterus adenoma | Uterus |
51.1 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Uterus adenoma | Uterus |
57.5 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Uterus adenoma | Uterus |
51.4 |
||
| C57BL/6 | Uterus cyst | Uterus |
0 |
||
| B6.129S1-Ptentm1Ppp/+ | Uterus cyst | Uterus |
31.1 |
||
| B6.Cg-Ptentm3.1Ppp/+ | Uterus cyst | Uterus |
22.5 |
||
| B6.Cg-Ptentm4.1Ppp/+ | Uterus cyst | Uterus |
21.6 |